Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.130
+0.040 (1.29%)
Jun 4, 2025, 1:47 PM - Market open
Perspective Therapeutics Stock Forecast
Stock Price Forecast
According to 9 professional analysts, the 12-month price target for Perspective Therapeutics stock ranges from a low of $6.00 to a high of $20. The average analyst price target of $13 forecasts a 315.34% increase in the stock price over the next year.
Price Target: $13.00 (+315.34%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Perspective Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 4 | 3 |
| Buy | 4 | 4 | 5 | 5 | 5 | 6 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +411.18% | Jun 3, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +155.59% | May 14, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $21 → $10 | Strong Buy | Maintains | $21 → $10 | +219.49% | Apr 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +219.49% | Mar 31, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $16 → $15 | Buy | Maintains | $16 → $15 | +379.23% | Mar 27, 2025 |
Financial Forecast
Revenue This Year
682.18K
from 1.45M
Decreased by -53.08%
Revenue Next Year
553.35K
from 682.18K
Decreased by -18.88%
EPS This Year
-1.30
from -1.23
EPS Next Year
-1.50
from -1.30
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.7M | 1.7M | 74.9M | ||
| Avg | 682,176 | 553,350 | 8.3M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.5% | 146.3% | 13,429.4% | ||
| Avg | -53.1% | -18.9% | 1,407.4% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.83 | -0.72 | -1.21 | ||
| Avg | -1.30 | -1.50 | -1.60 | ||
| Low | -1.83 | -2.04 | -2.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.